Protein tyrosine phosphatase receptor type C (PTPRC or CD45)

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Protein tyrosine phosphatase receptor type C (PTPRC), also known as CD45, is a transmembrane glycoprotein found on most hematopoietic cells.
• CD45 is crucial for T and B cell activation by regulating the balance between protein tyrosine kinase and phosphatase activity.
• Aberrant CD45 expression is implicated in immunodeficiency, autoimmunity, and malignancy.

Purpose of the Study:

• To review the structure and biological activities of PTPRC (CD45).
• To discuss the abnormal expression of CD45 in leukemia and lymphoma.
• To highlight the emerging role of CD45 in innate immunity.

Main Methods:

• Literature review of PTPRC (CD45) structure, function, and expression.
• Analysis of CD45's role in immune cell signaling pathways.
• Examination of CD45's involvement in hematological malignancies.

Main Results:

• CD45 acts upstream of diverse signaling networks, with cell-type-specific effects.
• Disruption of CD45-mediated signaling equilibrium can lead to immune system dysfunction.
• Abnormal CD45 expression is a hallmark of certain leukemias and lymphomas.

Conclusions:

• CD45 is a key regulator of both adaptive and innate immune responses.
• Understanding CD45's structure and function is vital for diagnosing and treating hematological malignancies.
• Further research into CD45's role in innate immunity is warranted.